RPG Life Sciences Board Meeting on Oct 29 for Unaudited Results

RPG Life Sciences Ltd has announced a Board of Directors meeting scheduled for October 29, 2026. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. A limited review report will also be taken on record. Concurrently, the company has closed its trading window for designated persons from October 1, 2026, until 48 hours after the results are publicly disclosed.